CD44<sup>+</sup>/CD24<sup>+</sup>表型的宫颈癌Siha细胞对顺铂的耐药及机制研究

刘　红; 王玉净; 边　磊

doi:10.3969/j.issn.1007-3969.2015.10.005

您当前的位置：

首页 >

文章列表页 >

CD44⁺/CD24⁺表型的宫颈癌Siha细胞对顺铂的耐药及机制研究

更新时间：2025-12-31

- CD44⁺/CD24⁺表型的宫颈癌Siha细胞对顺铂的耐药及机制研究
- Study on the chemoresistance of CD44+/CD24+ Siha cells to cisplatin and its mechanisms
- 中国癌症杂志 2015年25卷第10期页码：785-790
- 作者机构：
  
  1. 河北医科大学第四医院妇瘤科,河北,石家庄,050011
  2. 河北医科大学第四医院妇科,河北,石家庄,050011
- 作者简介：
- 基金信息：
  
  河北省科技支撑计划(14277770D);河北省杰出青年科学基金 (C2010002011)。
- DOI：10.3969/j.issn.1007-3969.2015.10.005
  中图分类号：
- 网络出版：2015-12-17，
  
  纸质出版：2015-12-17
- 稿件说明：
移动端阅览
刘　红,王玉净,边　磊,等. CD44

刘　红, 王玉净, 边　磊. Study on the chemoresistance of CD44+/CD24+ Siha cells to cisplatin and its mechanisms[J]. China Oncology, 2015, 25(10): 785-790.
刘　红,王玉净,边　磊,等. CD44 DOI： 10.3969/j.issn.1007-3969.2015.10.005.

刘　红, 王玉净, 边　磊. Study on the chemoresistance of CD44+/CD24+ Siha cells to cisplatin and its mechanisms[J]. China Oncology, 2015, 25(10): 785-790. DOI： 10.3969/j.issn.1007-3969.2015.10.005.

摘要

背景与目的：肿瘤干细胞的存在是肿瘤细胞抗拒化疗的原因之一。该研究探讨CD44

/CD24

宫颈癌Siha细胞对顺铂的耐药性及相关机制。方法：体外培养Siha细胞，流式荧光激活细胞分选仪分选CD44

/CD24

Siha细胞，噻唑蓝(thiazolyl blue，MTT)法检测不同浓度顺铂对细胞的体外抑制情况，采用流式细胞仪检测10 μg/mL顺铂作用于CD44

/CD24

Siha细胞24、48和72 h时的细胞凋亡率，实时定量聚合酶链式反应(quantitutive real-time polymerase chain reaction，qRT-PCR)和蛋白［质］印迹法(Western blot)检测CD44

/CD24

Siha细胞中Oct-4、ABCG2、Bcl-2的表达，同时设立亲代Siha细胞作为对照。结果：不同浓度顺铂(0.1、1、5、10、15和20 μg/mL)对CD44

/CD24

Siha细胞的增殖抑制作用较亲代Siha细胞小［(88.4±1.5)% vs (92.9±1.5)%，(79.9±1.0)% vs (84.7±1.1)%，(69. 8±0.8)% vs (75.1±2.9)%，(59.0±0.7)% vs (65.8±2.7)%，(49.6±0.9)% vs(52.1±0.5)%，(45.1±0.7)% vs (48.8±1.0)%，P0.05］；与亲代细胞相比，当10 μg/mL顺铂作用于CD44

/CD24

Siha细胞时，发现在24、48和72 h时的细胞凋亡率均较小［(3.05±0.16)% vs (5.17±0.27)%，(17.94±2.02)%vs (32.60±4.28)%和(40.14±3.01)% vs (56.62±5.32)%，P0.05］。qRT-PCR和Western blot实验均显示CD44

/CD24

Siha细胞高表达Oct-4、ABCG2和Bcl-2，与亲代Siha细胞比较差异有统计学意义(P=0.015)。结论：CD44

/CD24

Siha细胞可以抵抗顺铂诱导的细胞凋亡，具有化疗抵抗性，并且高表达肿瘤干细胞表面标志物如Oct-4和ABCG2，该结果在宫颈癌肿瘤干细胞的有效分选以及肿瘤靶向治疗方面有深远意义。

Abstract

Background and purpose: One of the reasons why cancer c

ells are resistant to chemotherapy is the existence of cancer stem cells. The purpose of this study was to investigate the chemoresistance of CD44

/CD24

Siha cells to cisplatin and its mechanisms. Methods: Siha cells were cultivated in vitro. The CD44

/CD24

Siha cells were sorted out by fluorescence activated cell sorter (FACS) and in vitro proliferation was detected by MTT assay after treatment with the different concentrations of cisplatin. The cell apoptosis rate was detected by flow cytometry after 10 μg/mL cisplatin acted on CD44

/CD24

Siha cells for 24

48 and 72 h. The relative mRNA and protein expressions of Bcl-2

Oct-4 and ABCG2 were detected by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot

respectively. Results: The survival rates of CD44

/CD24

Siha cells treated with different concentrations of cisplatin (0.1

15 and 20 μg/mL) were higher than those of their parental Siha cells [(88.42±1.51)% vs (92.87±1.5)%

(79.94±1.05)% vs (84.72±1.09)%

(69.78±0.81)% vs (75.13±2.86)%

(58.97±0.70)% vs (65.79±2.71)%

(49.60±0.88)% vs (52.10±0.52)%

(45.13±0.69)% vs (48.84±1.02)%

P0.05

]

. Compared with their parental Siha cells

the apoptosis rates of CD44

/CD24

Siha cells were lower after 10 μg/mL of cisplatin acting on them for 24

48 and 72 h

respectively [(3.05±0.16)% vs (5.17±0.27)%

(17.94±2.02)% vs (32.60±4.28)% and (40.14±3.01)% vs (56.62±5.32)%

P0.05

]

. The results from both qRT-PCR and Western blot indicated that Oct-4

ABCG2 and Bcl-2 were highly expressed on CD44

/CD24

Siha cells. A significant difference was found in Oct-4

ABCG2 and Bcl-2 expression between CD44

/CD24

Siha cells and their parental cells (P=0.0150.05). Conclusion: CD44

/CD24

Siha cells could be resistant to apoptosis induced by cisplatin and expressed high levels of cancer stem cell markers such as Oct-4 and ABCG2.

This study lays the basis for useful isolation and further targeted therapy of cervical cancer stem cells.

关键词

Keywords

references

浏览量

1639

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

腺苷酸活化蛋白激酶增强乳腺癌对多柔比星化疗敏感性的机制

miR-483-5p在上皮性卵巢癌中的表达及其对顺铂敏感性的影响

宫颈癌微环境TOX信号通路诱导T细胞耗竭介导的免疫逃逸机制

卡瑞利珠单抗联合化疗及靶向治疗在复发、转移及初治晚期宫颈癌中的疗效与安全性分析：一项回顾性队列研究

SERPINA3通过抑制铁死亡促进胰腺癌的恶性进展及吉西他滨耐药的机制研究

CD44+/CD24+表型的宫颈癌Siha细胞对顺铂的耐药及机制研究

Study on the chemoresistance of CD44+/CD24+ Siha cells to cisplatin and its mechanisms

DOI：10.3969/j.issn.1007-3969.2015.10.005

摘要

Abstract

关键词

Keywords

references

CD44⁺/CD24⁺表型的宫颈癌Siha细胞对顺铂的耐药及机制研究